Treatment of Fabry with stable α - Galactic antidote

摘要

p DISCLOSED IN THIS DOCUMENT, PROCEDURES FOR THE TREATMENT OF FABRY'S DISEASE THROUGH THE ALFA GALACTOSIDASE HUMAN PROTEIN ADMINISTRATION RECOMBINANT OF TWO-STABILIZED VEGETABLE PROCUREMENT, WHICH INCLUDES A LOW-RANGE THAT COVALENTLY UNITE BETWEEN SIacute; THROUGH A LINK FRACTION AND THE UNIT DOSE OF PROTEIN NA. THE PROTOCOLS DISCLOSED ARE SAFE, HAVE INTERVALS OF MORE THAN 2 WEEKS BETWEEN THE ADMINISTRATIONS AND SHOW A IMPORTANT IMPROVEMENT IN THE PATIENT DISEASE METERS,IN GB3 ACCUMULATION REDUCTION THEMES, PAIN AND GI PARAMETERS, KIDNEY STABILIZATION AND CARDIAC IN THE CLINICAL ENVIRONMENT. /p